Clinical Trials Sponsored by AURA Paris

Total 4471 results

AURA Paris

Completed

Immune Response Following COVID-19 in Hemodialysis Patients (IMMUNOVIDIAL)

COVID-19 | Cytokine Storm | Dialysis; Complications

France
Aura Biosciences

Recruiting

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (CoMpass)

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma | Indeterminate Lesions

United States
Medical University of Graz
Laura Bassi Fond; AUVA

Completed

Clinical Application of Mg Based Biodegradable Material for Fracture Fixation in the Adult Skeleton

Fracture of Medial Malleolus

Austria
Aura Biosciences

Active, not recruiting

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma

United States
Aura Biosciences

Terminated

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM) (IL)

Choroidal Melanoma | Indeterminate Lesions

United States
AURA Sante

Unknown

Long Term Physical Activity for Hemodialysis Patients

End Stage Renal Disease on Hemodialysis
Aura Biosciences

Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder Cancer

United States
Aura Biosciences

Recruiting

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Choroidal Melanoma | Indeterminate Lesions of Eye

United States
Aura Biosciences

Completed

Study in Subjects With Small Primary Choroidal Melanoma

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma

United States
AUVA

Recruiting

NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury

Acute Traumatic Spinal Cord Injury

Austria
AUVA

Completed

Magnetic Resonance Imaging and Functional Performance Outcome After ACL Repair With Internal Brace Technique

Anterior Cruciate Ligament Tear

Austria
AUVA

Completed

Extracorporeal Shockwave Treatment for Chronic Soft Tissue Wounds

Chronic Nonhealing Wounds

Austria
Akura Medical

Not yet recruiting

Safety and Effectiveness of the ATC System in the Treatment of Acute PE

Pulmonary Embolism Acute
Nura Medical

Not yet recruiting

Testing of Medication Dosing Software

Pediatric Emergency Medicine
Akura Medical

Not yet recruiting

Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism

Pulmonary Embolism Acute
Kura Oncology, Inc.

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML

Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Myeloid Sarcoma | Acute Myeloid Leukemia Recurrent | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute Leukemia | Refractory AML | NPM1 Mutation | Mixed Lineage Leukemia Gene Mutation | AML With Mutated NPM1 | KMT2Ar

United States
Aula Dental Avanzada

Recruiting

Soft Tissue Volume Changes in Posterior Socket Sealing Abutment.

Dental Implants

Spain
Aula Dental Avanzada

Recruiting

Surgical Extrusion: Volumetric and Insertion Analysis at 6 Months.

Tooth Extrusion | Tooth Fracture | Tooth Avulsion | Tooth Extruded

Spain
Kura Oncology, Inc.

Recruiting

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Advanced Malignant Neoplasm | Mixed Phenotype Acute Leukemia | Mixed Lineage Leukemia | Mixed Lineage Acute Leukemia

United States, Spain, United Kingdom, France, Germany, Canada, Belgium, Italy
Kura Oncology, Inc.

Available

Expanded Access to Ziftomenib

Acute Lymphoblastic Leukemia, With Appropriate Mutations | Acute Myeloid Leukemia, With NPM1 Mutations
Kura Oncology, Inc.

Terminated

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Advanced Solid Tumor

United States
Aula Dental Avanzada

Completed

Patient's Perception of Complications in Implantology.

Dental Implant Failed | Dental Prosthesis Failure

Spain
Kura Oncology, Inc.

Terminated

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Advanced Malignant Neoplasm

United States, Spain
Kura Oncology, Inc.

Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Thyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor

Spain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
Kura Oncology, Inc.

Completed

Investigation of Tipifarnib in Treatment of Subjects With PTCL That Have Not Responded to Standard Therapy. (PTCL)

Relapsed or Refractory Peripheral T-Cell Lymphoma

United States, Spain, Korea, Republic of
Kura Oncology, Inc.

Terminated

Tipifarnib in Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Acura Pharmaceuticals Inc.

Completed

Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users

Opioid-Related Disorders

United States
Groupe Hospitalier Paris Saint Joseph
Istituto Nazionale di Ricovero e Cura per Anziani

Completed

Diagnostic Value of Pulmonary Ultrasound in the Diagnosis of Ventilator-associated Pneumoniae (PAVM)

Sepsis | Ventilator-associated Pneumonia
Kura Oncology, Inc.

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Neoplasms by Histologic Type | Acute Myeloid Leukemia | Leukemia | Leukemia, Myeloid | Leukemia, Myeloid, Acute | AML | Acute Leukemia | Hematologic Malignancy | NPM1 Mutation | AML With Mutated NPM1 | KMT2Ar | MLL Rearrangement

United States
Aula Dental Avanzada

Recruiting

Volume and Attachment Changes in Autotransplanted Closed Apex Permanent Teeth

Surgery, Oral | Transplantation, Autologous | Autografts

Spain
Aula Dental Avanzada

Recruiting

Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants

Dental Implants

Spain
Aula Dental Avanzada

Recruiting

Soft Tissue Volume Changes After Immediate Implants With Two Different Techniques

Bone Resorption | Dental Implant | Tooth Extraction

Spain
Azura Ophthalmics
Avania

Completed

Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)

Contact Lens Discomfort

Australia
Kura Oncology, Inc.

Withdrawn

Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

NSCLC

United States
Kura Oncology, Inc.

Active, not recruiting

Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy (AIM-HN/SEQ-HN)

HNSCC | HRAS Gene Mutation

United States, Belgium, Spain, United Kingdom, Taiwan, Denmark, Korea, Republic of, Netherlands, Thailand, Germany, Malaysia, Austria, Italy, Greece, Australia, Norway
Aula Dental Avanzada

Completed

Patient Perception Between Two Emergency Treatments of Symptomatic Irreversible Pulpitis.

Irreversible Pulpitis

Spain
Azura Ophthalmics
Avania

Completed

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Meibomian Gland Dysfunction

Australia, New Zealand
Aula Dental Avanzada

Completed

Clinical Outcome of Dentsply Sirona EV Implants

Dental Implants

Spain
New Aera, Inc

Unknown

Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease

Interstitial Lung Disease | Chronic Obstructive Lung Disease
Kura Oncology, Inc.

Recruiting

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

HNSCC

United States
Kura Oncology, Inc.

Available

Expanded Access to Tipifarnib

HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
Aula Dental Avanzada

Completed

Comparing Two Anesthetic Techniques for Implant Placement

Anesthesia, Local | Dental Implant | Edentulous Jaw

Spain
Kura Oncology, Inc.

Completed

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia (CMML/AML)

Leukemia, Myelomonocytic, Chronic

United States
Acura Pharmaceuticals Inc.

Completed

Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse

Opioid Abuse

United States
Acura Pharmaceuticals Inc.

Completed

Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy

Pain
Cura Biotech LLC

Unknown

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Osteoarthritis | Rheumatoid Arthritis

United States
Umm Al-Qura University

Recruiting

Conservative Management for Adolescent Idiopathic Scoliosis

Scoliosis; Adolescence

Saudi Arabia
Umm Al-Qura University

Recruiting

Gait Training For Reducing Risk Of Fall in the Elderly

Fall

Saudi Arabia
Umm Al-Qura University

Not yet recruiting

Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women

Pathologic Processes | Polycystic Ovary Syndrome | Vitamin D Deficiency | IVF | Vitamin D Supplement | Female Infertility
Ludwig Boltzmann Gesellschaft
AUVA

Terminated

Polytrauma and Resuscitation Impact on Innate Immunity (PRIME)

Wounds and Injuries

Austria

Clinical Trials Sponsored by AURA Paris

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations